330
Participants
Start Date
September 17, 2007
Primary Completion Date
September 15, 2014
Study Completion Date
September 15, 2014
Prochymal®
Prochymal® IV infusion
Placebo
Prochymal® Placebo-matching IV infusion
Weill Cornell Medical College, New York
Mount Sinai School of Medicine, New York
University Hospital and Medical Center, Stony Brook
Rochester Institute for Digestive Diseases, Rochester
Rochester General Hospital, Rochester
Allegheney Center for Digestive Health, Pittsburgh
University of Pittsburgh, Pittsburgh
Chevy Chase Clinical Research, Chevy Chase
National Institutes of Health, Bethesda
University of Maryland, Baltimore, Baltimore
McGuire Research Institute, Richmond
Digestive and Liver Disease Specialists, Norfolk
Wake Forest University, Winston-Salem
Charlotte Gastroenterology and Hepatology, Charlotte
Pinehurst Medical Clinic, Pinehurst
Atlanta Gastroenterology Associates, Atlanta
Borland-Groover Clinic, Jacksonville
Shafran Gastroenterology Center, Winter Park
Clinical Research of West Florida, Clearwater
Gastroenterology Center of the Midsouth, Germantown
Nashville GI Specialists, Nashville
Vanderbilt University Medical Center, Nashville
University of Louisville Hospital, Louisville
University of Kentucky Hospital, Lexington
Indiana University Medical Center, Indianapolis
Center for Digestive Health, Troy
Center for Clinical Studies, Dearborn
University of Minnesota Hospital, Minneapolis
University of Chicago Medical Center, Chicago
Carle Clinic Association, Urbana
St Louis Center for Clinical Studies, St Louis
Cotton-O'Neil Clinical Research Center, Topeka
Gulf Coast Research, Baton Rouge
Gastroenterology United of Tulsa, Tulsa
Options Health Research, Tulsa
Baylor University Medical Center, Dallas
University of Texas Health Science Center, Houston
University of Texas Medical Branch, Galveston
Western States Clinical Research, Wheat Ridge
University of Southern California University Hospital, Los Angeles
University of California, San Francisco, San Francisco
Seattle Gastroenterology Associates, Seattle
Massachusetts General Hospital, Boston
Brigham and Womens Hospital, Boston
Clinical Pharmacology Study Group, Worcester
Dartmouth Hitchcock Medical Center, Lebanon
University of Vermont, Burlington
Royal Adelaide Hospital, Adelaide
Royal Melbourne Hospital, Melbourne
University of Otago, Christchurch
Waikato Hospital, Hamilton
University of Calgary, Calgary
University of Alberta Hospital, Edmonton
Health Science Centre, Winnipeg
London Health Sciences Centre, London
Mount Sinai Hospital, Toronto
Lead Sponsor
Mesoblast, Inc.
INDUSTRY